Priming Cross-Protective Bovine Viral Diarrhea Virus-Specific Immunity Using Live-Vectored Mosaic Antigens
Fig 7
Mosaic BVDV vaccine induced BVDV-2 specific neutralizing antibodies.
BVDV-2-specific neutralization titers against three BVDV type 2 strains were evaluated at A) two weeks post-boost; and B) one week pre-challenge. Mean group titers are represented by the bars. Statistically significant differences between the groups are denoted by asterisks *P<0.05; **P<0.01.